Kaijing Zhao

444 total citations
22 papers, 314 citations indexed

About

Kaijing Zhao is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Kaijing Zhao has authored 22 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 10 papers in Pharmacology and 7 papers in Molecular Biology. Recurrent topics in Kaijing Zhao's work include Drug Transport and Resistance Mechanisms (11 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Kaijing Zhao is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Kaijing Zhao collaborates with scholars based in China, United Kingdom and Taiwan. Kaijing Zhao's co-authors include Xiaodong Liu, Li Liu, Zeyu Zhong, Binbin Sun, Zhongjian Wang, Chen Yang, Liang Zhu, Yang Chen, Mian Zhang and Ping Xu and has published in prestigious journals such as Cancer Research, Journal of Neurochemistry and Biochemical Pharmacology.

In The Last Decade

Kaijing Zhao

22 papers receiving 312 citations

Peers

Countries citing papers authored by Kaijing Zhao

Since Specialization

Citations

This map shows the geographic impact of Kaijing Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaijing Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaijing Zhao more than expected).

Fields of papers citing papers by Kaijing Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaijing Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaijing Zhao. The network helps show where Kaijing Zhao may publish in the future.

Co-authorship network of co-authors of Kaijing Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Kaijing Zhao. A scholar is included among the top collaborators of Kaijing Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaijing Zhao. Kaijing Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SHR-A1811 (antibody-drug conjugate) in advanced HER2-mutant non-small cell lung cancer: a multicenter, open-label, phase 1/2 study 2024 ·Signal Transduction and Targeted Therapy ·Ziming Li, Zhengbo Song, (unknown), Nong Yang, Yongsheng Wang, (unknown), Zibin Liang, Sheng Hu, (unknown), (unknown), Yan Wang, (unknown), Kaijing Zhao, Ke Song, You Li, Wei Shi, Shun Lü	13
2	Abstract CT204: Safety, tolerability, pharmacokinetics, and efficacy of SHR-A1811, an antibody-drug conjugate, in patients with advanced HER2-mutant non-small cell lung cancer (NSCLC): a multicenter, open-label, phase 1/2 study 2023 ·Cancer Research ·Shun Lü, (unknown), Wei Hong, (unknown), Nong Yang, Sheng Hu, Zibin Liang, Yongsheng Wang, Yan Wang, Min Peng, Yan Yu, You Li, (unknown), Kaijing Zhao	2
3	Prediction of pyrotinib exposure based on physiologically-based pharmacokinetic model and endogenous biomarker 2022 ·Frontiers in Pharmacology ·Miao Zhang, (unknown), Xueting Yao, (unknown), Kaijing Zhao, Wenqian Wang, Xue Zhang, Xijing Chen, Dongyang Liu	6
4	Population pharmacokinetic modeling of pyrotinib in patients with HER2-positive advanced or metastatic breast cancer 2021 ·European Journal of Pharmaceutical Sciences ·Haini Wen, (unknown), Da Xu, Kaijing Zhao, Zheng Jiao	7
5	Physiologically based pharmacokinetic–pharmacodynamic modeling for prediction of vonoprazan pharmacokinetics and its inhibition on gastric acid secretion following intravenous/oral administration to rats, dogs and humans 2020 ·Acta Pharmacologica Sinica ·Weimin Kong, Binbin Sun, Zhongjian Wang, Xiaoke Zheng, Kaijing Zhao, Chen Yang, Jiaxin Zhang, (unknown), Liang Zhu, Rujun Xu, Ping Li, Li Liu, Xiaodong Liu	17
6	Characteristics of β-oxidative and reductive metabolism on the acyl side chain of cinnamic acid and its analogues in rats 2019 ·Acta Pharmacologica Sinica ·Kaijing Zhao, Chen Yang, (unknown), (unknown), (unknown), Hanyu Yang, Liang Zhu, Ming Liu, (unknown), (unknown), Tingting Yang, (unknown), Li Liu, Xiaodong Liu	6
7	Impairment of Intestinal Monocarboxylate Transporter 6 Function and Expression in Diabetic Rats Induced by Combination of High-Fat Diet and Low Dose of Streptozocin: Involvement of Butyrate–Peroxisome Proliferator-Activated Receptor-γ Activation 2019 ·Drug Metabolism and Disposition ·Feng Xu, Liang Zhu, (unknown), Junjie Zhou, (unknown), Ping Li, Wenjing Xuan, (unknown), Kaijing Zhao, Weimin Kong, Yuanyuan Qin, Limin Liang, Li Liu, Xiaodong Liu	13
8	Increase in P-glycoprotein levels in the blood-brain barrier of partial portal vein ligation /chronic hyperammonemia rats is medicated by ammonia/reactive oxygen species/ERK1/2 activation: In vitro and in vivo studies 2019 ·European Journal of Pharmacology ·(unknown), Junjie Zhou, Ping Li, (unknown), Binbin Sun, Ying Li, Chen Yang, Kaijing Zhao, Tingting Yang, Liang Zhu, (unknown), Xiaodong Liu, Li Liu	13
9	Prediction of Atorvastatin Pharmacokinetics in High-Fat Diet and Low-Dose Streptozotocin-Induced Diabetic Rats Using a Semiphysiologically Based Pharmacokinetic Model Involving Both Enzymes and Transporters 2019 ·Drug Metabolism and Disposition ·Zhongjian Wang, Hanyu Yang, (unknown), Kaijing Zhao, Chen Yang, Limin Liang, Ping Li, Nan Chen, (unknown), Xiangping Zhang, Xiaodong Liu, Li Liu	26
10	Simultaneously predict pharmacokinetic interaction of rifampicin with oral versus intravenous substrates of cytochrome P450 3A/P‑glycoprotein to healthy human using a semi-physiologically based pharmacokinetic model involving both enzyme and transporter turnover 2019 ·European Journal of Pharmaceutical Sciences ·(unknown), Kaijing Zhao, Yang Chen, Li Liu, Xiaodong Liu	19
11	Short-chain fatty acids oppositely altered expressions and functions of intestinal cytochrome P4503A and P-glycoprotein and affected pharmacokinetics of verapamil following oral administration to rats 2019 ·Journal of Pharmacy and Pharmacology ·(unknown), (unknown), Weimin Kong, Zhongjian Wang, Shuting Wang, Kaijing Zhao, Yang Chen, Xiaodong Liu, Li Liu	11
12	Predicting Antitumor Effect of Deoxypodophyllotoxin in NCI-H460 Tumor-Bearing Mice on the Basis of In Vitro Pharmacodynamics and a Physiologically Based Pharmacokinetic-Pharmacodynamic Model 2018 ·Drug Metabolism and Disposition ·Chen Yang, Kaijing Zhao, Fei Liu, Ying Li, Zeyu Zhong, (unknown), Xiaodong Liu, Li Liu	11
13	Acute liver failure enhances oral plasma exposure of zidovudine in rats by downregulation of hepatic UGT2B7 and intestinal P-gp 2017 ·Acta Pharmacologica Sinica ·(unknown), Mingxing Miao, Binbin Sun, Zhongjian Wang, (unknown), Yang Chen, Kaijing Zhao, Xiaodong Liu, Li Liu	21
14	Acute liver failure impairs function and expression of breast cancer‐resistant protein (BCRP) at rat blood–brain barrier partly via ammonia‐ROS‐ERK1/2 activation 2016 ·Journal of Neurochemistry ·Ying Li, Ji Zhang, Ping Xu, Binbin Sun, Zeyu Zhong, Can Liu, (unknown), Yang Chen, (unknown), Kaijing Zhao, Li Liu, Xiaodong Liu	29
15	Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity 2016 ·Acta Pharmacologica Sinica ·Zeyu Zhong, Binbin Sun, (unknown), (unknown), (unknown), (unknown), Fan Wang, Kaijing Zhao, Ping Xu, Mian Zhang, Ying Li, Yang Chen, Li Liu, Xia Lun-zhu, Xiaodong Liu	30
16	Interspecies differences in metabolism of deoxypodophyllotoxin in hepatic microsomes from human, monkey, rat, mouse and dog 2016 ·Drug Metabolism and Pharmacokinetics ·(unknown), Yang Chen, Fei Liu, Zeyu Zhong, Kaijing Zhao, (unknown), Fan Wang, (unknown), Zhongjian Wang, Li Liu, Xiaodong Liu	8
17	Prediction of Deoxypodophyllotoxin Disposition in Mouse, Rat, Monkey, and Dog by Physiologically Based Pharmacokinetic Model and the Extrapolation to Human 2016 ·Frontiers in Pharmacology ·Chen Yang, Kaijing Zhao, Fei Liu, (unknown), Zeyu Zhong, Mingxing Miao, Xiaodong Liu, Li Liu	16
18	In vitro metabolism of l-corydalmine, a potent analgesic drug, in human, cynomolgus monkey, beagle dog, rat and mouse liver microsomes 2016 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), (unknown), Zeyu Zhong, (unknown), Yang Chen, Fan Wang, (unknown), Ping Xu, Kaijing Zhao, Zhongjian Wang, Li Liu, Xiaodong Liu	10
19	Paroxetine decreased plasma exposure of glyburide partly via inhibiting intestinal absorption in rats 2015 ·Drug Metabolism and Pharmacokinetics ·Shuwen Jiang, Weiman Zhao, Yang Chen, Zeyu Zhong, Mian Zhang, (unknown), Ping Xu, Kaijing Zhao, Ying Li, Li Liu, Xiaodong Liu	8
20	Involvement of pregnane X receptor in the impaired glucose utilization induced by atorvastatin in hepatocytes 2015 ·Biochemical Pharmacology ·(unknown), (unknown), Ping Xu, (unknown), Zeyu Zhong, Binbin Sun, Feng Li, Mian Zhang, Kaijing Zhao, (unknown), Zhongjian Wang, Liang Zhu, Li Liu, Xiaodong Liu	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact